News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
134,541 Results
Type
Article (4361)
Company Profile (91)
Press Release (130085)
Multimedia
Podcasts (3)
Webinars (7)
Section
Business (42227)
Career Advice (210)
Deals (6183)
Drug Delivery (13)
Drug Development (17471)
Employer Resources (18)
FDA (1499)
Job Trends (2814)
News (66463)
Policy (3669)
Tag
Academia (297)
Accelerated approval (1)
Adcomms (1)
Allergies (25)
Alliances (11540)
ALS (37)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (63)
Approvals (1553)
Artificial intelligence (80)
Autoimmune disease (32)
Automation (9)
Bankruptcy (37)
Best Places to Work (2274)
BIOSECURE Act (14)
Biosimilars (21)
Biotechnology (87)
Bladder cancer (33)
Brain cancer (11)
Breast cancer (160)
Cancer (1044)
Cardiovascular disease (36)
Career advice (200)
Career pathing (5)
CAR-T (91)
Cell therapy (251)
Cervical cancer (9)
Clinical research (14949)
Collaboration (425)
Compensation (217)
Complete response letters (4)
COVID-19 (448)
CRISPR (20)
C-suite (238)
Cystic fibrosis (38)
Data (1350)
Depression (19)
Diabetes (85)
Diagnostics (738)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (66)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (43)
Earnings (13163)
Editorial (4)
Employer resources (18)
Events (25866)
Executive appointments (364)
FDA (2026)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (8)
Funding (380)
Gene editing (41)
Generative AI (8)
Gene therapy (132)
GLP-1 (145)
Government (361)
Guidances (67)
Healthcare (1542)
HIV (6)
Huntington's disease (10)
IgA nephropathy (27)
Immunology and inflammation (54)
Immuno-oncology (1)
Indications (13)
Infectious disease (495)
Inflammatory bowel disease (66)
Inflation Reduction Act (1)
Influenza (31)
Intellectual property (61)
Interviews (18)
IPO (2976)
IRA (4)
Job creations (670)
Job search strategy (185)
Kidney cancer (3)
Labor market (15)
Layoffs (41)
Leadership (1)
Legal (643)
Liver cancer (17)
Longevity (2)
Lung cancer (103)
Lymphoma (100)
Machine learning (8)
Management (4)
Manufacturing (175)
MASH (17)
Medical device (413)
Medtech (415)
Mergers & acquisitions (3492)
Metabolic disorders (183)
Multiple sclerosis (41)
NASH (1)
Neurodegenerative disease (43)
Neuropsychiatric disorders (10)
Neuroscience (641)
NextGen: Class of 2025 (862)
Non-profit (286)
Now hiring (7)
Obesity (77)
Opinion (39)
Ovarian cancer (55)
Pain (32)
Pancreatic cancer (56)
Parkinson's disease (77)
Partnered (5)
Patents (109)
Patient recruitment (103)
Peanut (16)
People (16906)
Pharmaceutical (8)
Phase I (5897)
Phase II (7149)
Phase III (3675)
Pipeline (736)
Policy (29)
Postmarket research (211)
Preclinical (2572)
Press Release (51)
Prostate cancer (35)
Psychedelics (5)
Radiopharmaceuticals (47)
Rare diseases (121)
Real estate (1461)
Recruiting (10)
Regulatory (3243)
Reports (15)
Research institute (309)
Resumes & cover letters (20)
Rett syndrome (7)
RNA editing (2)
RSV (11)
Schizophrenia (17)
Series A (72)
Series B (55)
Service/supplier (2)
Sickle cell disease (16)
Special edition (2)
Spinal muscular atrophy (36)
Sponsored (5)
Startups (988)
State (1)
Stomach cancer (2)
Supply chain (21)
Tariffs (9)
The Weekly (3)
Vaccines (116)
Venture capital (12)
Weight loss (34)
Women's health (4)
Worklife (2)
Date
Today (50)
Last 7 days (203)
Last 30 days (737)
Last 365 days (8615)
2025 (6894)
2024 (9203)
2023 (9962)
2022 (12067)
2021 (12698)
2020 (9902)
2019 (6714)
2018 (5308)
2017 (6092)
2016 (5612)
2015 (6480)
2014 (4953)
2013 (4081)
2012 (4411)
2011 (4877)
2010 (4517)
Location
Africa (143)
Alabama (44)
Alaska (1)
Arizona (31)
Arkansas (3)
Asia (8789)
Australia (2051)
California (2991)
Canada (779)
China (202)
Colorado (48)
Connecticut (109)
Delaware (42)
Europe (19190)
Florida (293)
Georgia (44)
Hawaii (2)
Idaho (10)
Illinois (157)
India (12)
Indiana (154)
Iowa (2)
Japan (77)
Kansas (13)
Kentucky (3)
Louisiana (2)
Maine (2)
Maryland (343)
Massachusetts (2182)
Michigan (88)
Minnesota (131)
Mississippi (1)
Missouri (9)
Montana (9)
Nebraska (2)
Nevada (14)
New Hampshire (5)
New Jersey (598)
New Mexico (6)
New York (694)
North Carolina (390)
North Dakota (5)
Northern California (1391)
Ohio (57)
Oklahoma (7)
Oregon (5)
Pennsylvania (545)
Puerto Rico (5)
Rhode Island (5)
South America (202)
South Carolina (3)
Southern California (1186)
Tennessee (21)
Texas (395)
United States (9515)
Utah (26)
Virginia (22)
Washington D.C. (9)
Washington State (431)
West Virginia (1)
Wisconsin (16)
134,541 Results for "sana biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sana Biotechnology to Present at September 2025 Investor Conferences
August 26, 2025
·
3 min read
Press Releases
Sana Biotechnology Announces Pricing of Public Offering
August 7, 2025
·
3 min read
Press Releases
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 21, 2025
·
2 min read
Press Releases
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates
August 12, 2025
·
20 min read
Press Releases
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
August 7, 2025
·
3 min read
Press Releases
Sana Biotechnology to Present at June 2025 Investor Conferences
May 29, 2025
·
3 min read
Layoffs
Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.
November 5, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
May 13, 2025
·
3 min read
Press Releases
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
May 9, 2025
·
17 min read
Press Releases
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
June 10, 2025
·
3 min read
1 of 13,455
Next
